multi-stratHard to copy

Farallon Capital Management

Andrew Spokes · CIK 0000909661 · latest 13F for 2026-06-30 filed 2026-08-14

Estimated from 13F holdings — long US equities only; follow-the-filing returns are net of an assumed 10 bps per unit of turnover.

Annualised 3Y (copying filings)
+22.8%
SPY +22.9% · alpha -0.1%/yr
Since start, annualised
+16.4%
Aug 2022 – Oct 2026 · SPY +17.3%
TTM (copy, net)
+24.4%
SPY +16.2%
YTD (copy, net)
+15.6%
SPY +14.4%
13F-implied TTM
+27.2%
held from quarter end
Coverage
80%
17 quarters of history
13F long book
$16.9B
82 positions
Concentration
56%
top 10 · avg turnover 16%/qtr

About the fund

Farallon Capital Management is an American multi-strategy investment firm headquartered in San Francisco. The firm manages capital for institutional and private investors, investing in public and private assets globally across a variety of strategies.

Multi-strategy

Strategy

Multi-strategy, including credit, long/short equity, merger arbitrage, risk arbitrage, and real estate.

Investment approach

Farallon employs a bottom-up fundamental research and analysis approach, seeking global investment opportunities across public and private assets. The firm maintains flexible investment parameters, allowing capital to shift among strategies and asset classes based on prevailing opportunities and risk-adjusted returns. Risk is managed through rigorous analysis, portfolio-level analytics, and hedging techniques.

History

Founded by Thomas Steyer in 1986, the firm initially focused on merger arbitrage. Over the decades, it expanded its strategies to include credit, real estate, and direct investments, and established a global presence with offices in cities including London, Singapore, Hong Kong, Tokyo, São Paulo, and New York. The firm underwent a leadership transition with the retirement of Thomas Steyer and the promotion of Andrew Spokes, followed by the appointment of Nicolas Giauque as Managing Partner in 2025.

Notable positions & campaigns

  • Bank Central Asia2002 — Farallon bought control of the Indonesian financial institution for $531 million and sold its stake for a profit in 2006.
  • Mills Corp2007 — Farallon purchased the real estate investment trust in partnership with Simon Property Group and other hedge funds.
  • Toshiba — Farallon was one of the largest shareholders in the Japanese electronics company.

Profile generated 2026-10-09 from public sources; may be incomplete or out of date.

Founded by
Thomas Steyer
Founded
1986
HQ
San Francisco, U.S.
Reported AUM
$43.6bn (as of December 31, 2025)
Website
faralloncapital.com

Management

  • Nicolas GiauqueManaging Partner
  • Andrew J.M. SpokesPrincipal owner

Holdings heatmap

Latest 13F (2026-06-30): top 50 positions grouped by sector, sized by weight, coloured by the change in weight since the previous 13F.

Holdings map

Each tile is a position, sized by reported value and coloured by the stock's own price return (red down, green up) — the LiquidRound / finviz-style map.

Copy portfolio vs SPY

Growth of $1 following each filing the trading day after it was filed.

Top holdings

Latest 13F (2026-06-30).

# Ticker Issuer Sector Value Weight
1 RVMD REVOLUTION MEDICINES INC Healthcare $2.5B 15.0%
2 — ELECTRONIC ARTS INC — $1.6B 9.6%
3 BBIO BRIDGEBIO PHARMA INC Healthcare $800M 4.7%
4 PTGX PROTAGONIST THERAPEUTICS INC Healthcare $778M 4.6%
5 EXEL EXELIXIS INC Healthcare $733M 4.3%
6 LQDA LIQUIDIA CORPORATION Healthcare $667M 3.9%
7 AMZN AMAZON COM INC Consumer Cyclical $628M 3.7%
8 LNTH LANTHEUS HLDGS INC Healthcare $619M 3.7%
9 NTRA NATERA INC Healthcare $602M 3.6%
10 UNH UNITEDHEALTH GROUP INC Healthcare $528M 3.1%
11 TMO THERMO FISHER SCIENTIFIC INC Healthcare $526M 3.1%
12 — ROIVANT SCIENCES LTD — $506M 3.0%
13 — AON PLC — $459M 2.7%
14 BSX BOSTON SCIENTIFIC CORP Healthcare $449M 2.7%
15 AVGO BROADCOM INC Technology $435M 2.6%
16 MSFT MICROSOFT CORP Technology $415M 2.4%
17 TNGX TANGO THERAPEUTICS INC Healthcare $384M 2.3%
18 KKR KKR & CO INC Financial Services $378M 2.2%
19 SNPS SYNOPSYS INC Technology $370M 2.2%
20 BEAM BEAM THERAPEUTICS INC Healthcare $351M 2.1%
21 — CRINETICS PHARMACEUTICALS IN — $336M 2.0%
22 GRAL GRAIL INC Healthcare $284M 1.7%
23 WAB WABTEC Industrials $241M 1.4%
24 IMVT IMMUNOVANT INC Healthcare $224M 1.3%
25 TWST TWIST BIOSCIENCE CORP Healthcare $220M 1.3%

Sector mix

Top-25 holdings by weight.

Healthcare57.3%
Other / unknown17.3%
Technology7.2%
Consumer Cyclical3.7%
Financial Services2.2%
Industrials1.4%

Changes this quarter

Move Ticker Issuer Prev wt Now wt
trimmed MSFT MICROSOFT CORP 5.2% 2.4%
exited SCHW SCHWAB CHARLES CORP 2.2% 0.0%
trimmed — AON PLC 4.8% 2.7%
exited GOOG ALPHABET INC 1.7% 0.0%
trimmed AMZN AMAZON COM INC 5.2% 3.7%
exited V VISA INC 1.5% 0.0%
added — ROIVANT SCIENCES LTD 1.6% 3.0%
exited DIS DISNEY WALT CO 1.4% 0.0%
exited MA MASTERCARD INCORPORATED 1.3% 0.0%
exited MCK MCKESSON CORP 1.2% 0.0%
exited — CENTESSA PHARMACEUTICALS PLC 1.1% 0.0%
added TNGX TANGO THERAPEUTICS INC 1.1% 2.3%
added IMVT IMMUNOVANT INC 0.2% 1.3%
trimmed WAB WABTEC 2.4% 1.4%
added TWST TWIST BIOSCIENCE CORP 0.4% 1.3%
exited TYRA TYRA BIOSCIENCES INC 0.8% 0.0%
trimmed AVGO BROADCOM INC 3.3% 2.6%
trimmed SNPS SYNOPSYS INC 2.9% 2.2%
added GRAL GRAIL INC 1.0% 1.7%
added BBIO BRIDGEBIO PHARMA INC 4.1% 4.7%

Quarterly copy returns

Each 13F held from the day after filing until the next filing.

13F period Held Copy SPY Alpha Coverage
2026-06-30 2026-08-17 → 2026-10-08 -6.4% +0.4% -6.8% 75%
2026-03-31 2026-05-18 → 2026-08-17 +18.2% +4.9% +13.4% 82%
2025-12-31 2026-02-18 → 2026-05-18 +10.2% +7.9% +2.3% 82%
2025-09-30 2025-11-17 → 2026-02-18 -0.3% +3.4% -3.7% 81%
2025-06-30 2025-08-15 → 2025-11-17 +7.2% +3.7% +3.5% 81%
2025-03-31 2025-05-16 → 2025-08-15 +2.1% +8.6% -6.5% 81%
2024-12-31 2025-02-18 → 2025-05-16 -0.9% -2.5% +1.6% 81%
2024-09-30 2024-11-15 → 2025-02-18 +1.8% +4.7% -2.9% 78%
2024-06-30 2024-08-15 → 2024-11-15 +7.8% +6.2% +1.6% 80%
2024-03-31 2024-05-16 → 2024-08-15 +5.7% +4.9% +0.7% 77%
2023-12-31 2024-02-15 → 2024-05-16 +6.0% +5.6% +0.3% 83%
2023-09-30 2023-11-15 → 2024-02-15 +12.9% +12.1% +0.8% 66%
2023-06-30 2023-08-15 → 2023-11-15 -1.7% +1.9% -3.6% 77%
2023-03-31 2023-05-16 → 2023-08-15 +5.6% +8.4% -2.8% 71%
2022-12-31 2023-02-15 → 2023-05-16 -1.2% -0.5% -0.6% 78%
2022-09-30 2022-11-15 → 2023-02-15 +6.5% +4.4% +2.1% 66%

Filing dates

  • 2026-08-1413F-HR for 2026-06-30 · $21.7B · 89 rows
  • 2026-08-1413F-HR/A for 2026-03-31 · $1.5B · 1 rows
  • 2026-08-1413F-HR/A for 2025-12-31 · $1.0B · 1 rows
  • 2026-05-1513F-HR/A for 2025-12-31 · $884M · 2 rows
  • 2026-05-1513F-HR for 2026-03-31 · $17.5B · 172 rows
  • 2026-02-1713F-HR/A for 2025-09-30 · $24.4B · 144 rows
  • 2026-02-1713F-HR/A for 2025-06-30 · $140M · 1 rows
  • 2026-02-1713F-HR/A for 2025-03-31 · $274M · 1 rows
  • 2026-02-1713F-HR/A for 2024-12-31 · $85M · 1 rows
  • 2026-02-1713F-HR for 2025-12-31 · $21.2B · 151 rows
  • 2025-11-1413F-HR/A for 2023-09-30 · $40M · 1 rows
  • 2025-11-1413F-HR for 2025-09-30 · $24.4B · 144 rows

Use it with your AI

A public skill.md describes this copy portfolio (rules + parameters) for ChatGPT or Claude.

View skill.md

Copy this fund

Start a paper copy-bot that rebalances the day after each new filing.

Start a copy-bot